Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis

By afschroeder • June 25, 2025

Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T. Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2025 Jun 23;11(3):00738-2024. doi: 10.1183/23120541.00738-2024. PMID: 40551789; PMCID: PMC12183712.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

Hanif I, Assassi S, Mayes MD, McMahan ZH, Zhang M, Charles J, VanBuren JM, Alvey JS, Ghaffari K, Bernstein EJ, Castelino FV, Chung L, Evnin[...]

Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial

Fung CH, Mak S, Ash G, Der-McLeod E, Ereso J, Naeem S, Liu J, Ghadimi S, Te TT, Chan V, Hurtado J, Wong S, Zeidler[...]

Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta-Analysis

Kawai K, Muhere CF, Lemos EV, Francis JM. Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc. 2025 Oct[...]